Info
MiGenTra is a healthcare transforming medicines company, and a subsidiary of ProBioGen, with a focus on high quality medicines at affordable prices. The company allows for product development in the field of Biosimilars, Cell and Gene Therapies and vaccines especially for Egypt, the Middle East and Africa, and will therefore provide access to key healthcare transforming medicines, while strengthening regional and local manufacturing capacity in the region. MiGenTra combines scientific and manufacturing subject matter expertise from both contributing companies, ProBioGen and Minapharm Pharmaceuticals and is headquartered in Berlin, Germany and has access to a site in Cairo, Egypt, where the main manufacturing plant is located.
- Website
-
http://www.migentra.com
Externer Link zu MiGenTra GmbH
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2021
Orte
-
Primär
Wegbeschreibung
Herbert-Bayer Straße 4
Berlin, 13086, DE
Beschäftigte von MiGenTra GmbH
-
Bertrand Chol
Director Bioproduction / MSc, MBA graduate Biotechnology, Director CMC, Bioprocess, mAbs, biosimilars, Cell and gene therapy, CART cell, proteins…
-
Frederic Bouvier, MSc, MBA
Life Sciences Executive | General Manager | Management Board | Biopharma, CDMO, Consulting | Growth Accelerator | Strategic Vision, Operational…
-
Jan Rohde
Senior Director Biotechnology at Minapharm Pharmaceuticals
-
Dina Soliman
Director of Strategic Operations, Business Development and Export at Minapharm Pharmaceuticals. Business Board Member at MiGenTra GmbH